RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

Abbott Laboratories

A collection of news and information related to Abbott Laboratories published by this site and its partners.

Top Abbott Laboratories Articles

Displaying items 13-24
  • Eddie Murray linked to insider trading probe

    Eddie Murray linked to insider trading probe
    Eddie Murray, the former Orioles Hall of Famer, has been linked to an investigation by federal authorities in a wide-ranging insider trading case that already has ensnared teammate Doug DeCinces, according to a Reuters report. Investigators have been...
  • Good morning, Baltimore: Need to know for Thursday

    Good morning, Baltimore: Need to know for Thursday
    WEATHER The National Weather Service is calling for Thursday to be sunny and hot in the Baltimore area, with a high near 99. A heat advisory is in effect until 10 p.m. for the Baltimore area. Forecasters warn that heat index values will be as high as 105...
  • Trail of stock deals led to DeCinces insider trading accusation

    Trail of stock deals led to DeCinces insider trading accusation
    The stock purchases began in December 2008, less than two months after discussions kicked off about the corporate acquisition of a California medical products manufacturer. By the time the deal was announced on Jan. 12, 2009, former Orioles third baseman...
  • Exclusive - India's Lupin, U.S. firms weigh bids for GSK's mature drugs: sources

    LONDON/MUMBAI (Reuters) - Indian generics firm Lupin , some U.S. drugmakers looking for a tax-saving deal in Europe and private equity funds are planning to bid for a range of older drugs being auctioned by GlaxoSmithKline (GSK) , five sources familiar...
  • Tax inversion threaten states' revenue

    American companies that merge with foreign competitors to lower their federal taxes also cut their state taxes, leaving states to mostly watch helplessly as their tax revenue drains away. A rash of companies has been buying up foreign competitors and...
  • AbbVie-Shire deal puts more pressure on Congress to overhaul tax code

    AbbVie-Shire deal puts more pressure on Congress to overhaul tax code
    A massive pharmaceutical merger that will send the headquarters of a major U.S. drug maker overseas ramps up pressure on Congress to curtail the ability of companies to shelter foreign earnings. Illinois drug maker AbbVie Inc. said Friday that it...
  • AbbVie to buy Shire in $55-billion deal that slashes tax rate

    AbbVie to buy Shire in $55-billion deal that slashes tax rate
    Illinois drug maker AbbVie Inc. said Friday it would buy European rival Shire for $55 billion and reincorporate in Britain, allowing the company to slash its tax rate in the latest move by an American firm to shelter its foreign earnings. The deal...
  • AbbVie to Buy Shire for $54.8 billion in biggest inversion

    AbbVie to Buy Shire for $54.8 billion in biggest inversion
    AbbVie Inc. is buying Shire for nearly $55 billion, the largest deal in a year filled with merger and acquisition activity, and the latest example of companies taking foreign addresses to cut taxes. The deal will allow North Chicago-based pharmaceutical...
  • AbbVie to buy drugmaker Shire in nearly $55 billion deal

    AbbVie to buy drugmaker Shire in nearly $55 billion deal
    AbbVie Inc. has inked a nearly $55 billion deal to acquire drugmaker Shire PLC, the companies announced in a joint statement Friday morning. The deal, the largest of a year filled with merger and acquisition activity, will allow the North Chicago-...
  • Obama takes aim at firms that shift profits overseas to avoid taxes

    Obama takes aim at firms that shift profits overseas to avoid taxes
    The Obama administration called out corporate America for its growing use of a tactic to avoid paying taxes and urged lawmakers to act quickly to put a halt to the maneuver. In a sharply worded letter to key congressional tax code writers, Treasury...
  • Baxter has no plans for inversion with spinoff

     Baxter has no plans for inversion with spinoff
    While its peers in the northern suburbs and around the pharmaceutical industry have been lining up foreign mergers to help sidestep U.S. taxes, Baxter International said Thursday it has no plans to jump on the bandwagon. The Deerfield-based health...
  • Abbott, AbbVie part of red-hot pharmaceutical deal market

     Abbott, AbbVie part of red-hot pharmaceutical deal market
    AbbVie Inc. appears to be on the verge of a $53.7 billion takeover that would change its corporate address to the United Kingdom. Abbott Laboratories agreed Monday to sell part of its generic drug business for $5.3 billion, structuring the sale in a way...